Fidelity International’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Fidelity International's XBI Position: Q2 2026 in Review
Fidelity International increased its State Street SPDR S&P Biotech ETF (XBI) stake by 238% in Q2 2026, buying an estimated $23.1M and bringing the position to 242,331 shares worth $38.3M. The position accounts for 0.03% of the portfolio, ranked #391.
Fidelity International first reported a position in XBI in Q4 2023 and has held it in 8 quarters since. 842 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Fidelity International held 242,331 shares of State Street SPDR S&P Biotech ETF worth $38.3M as of Q2 2026.
- Fidelity International bought 170,603 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $23.1M.
- State Street SPDR S&P Biotech ETF made up 0.03% of Fidelity International's portfolio in Q2 2026, its #391 holding.
- Fidelity International first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 8 quarters since.
- 842 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.